The Astigmatism market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.
Astigmatism: An Overview
Astigmatism is a common vision condition that causes blurred vision. It occurs when the cornea (the clear front cover of the eye) is irregularly shaped or sometimes because of the curvature of the lens inside the eye and is alos known as corneal astigmatism, which is the main type of astigmatism.
The goal of treating astigmatism is to improve vision clarity and eye comfort. Treatments are corrective lenses or refractive surgery. Wearing corrective lenses treats astigmatism by counteracting uneven curvatures of the cornea and lens. The types of corrective lenses include eyeglasses and contact lenses. Refractive surgery improves vision and reduces the need for eyeglasses or contact lenses. The types of refractive surgery for astigmatism include laser-assisted in-situ keratomileusis (LASIK), laser-assisted subepithelial keratectomy (LASEK), photorefractive keratectomy (PRK), epi-LASIK and others.
Astigmatism Market Key Facts
-
As per a study conducted by Knyazer et. al., (2019) titled “Prevalence of astigmatism before routine cataract surgery: comparison between bedouin and jewish population in southern Israel”, more than 25% of patients had astigmatism more than 1.5D. Higher astigmatism was found in men than in women.
-
According to an article published by OMICS International Journals titled “Astigmatism”, the prevalence of astigmatism in Israel, from data of medical examinations of an unselected population of 312,149 subjects ages 17 to 19 years, astigmatism in both eyes was found in 16.27% of the population.
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Astigmatism market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives complete detail of the Astigmatism market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.
Astigmatism Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.
Astigmatism Epidemiology Segmentation
-
Incident/Prevalent Population of Astigmatism
-
Diagnosed Cases of Astigmatism
-
Treatable Cases of Astigmatism
Request for Sample PDF Report – https://www.delveinsight.com/sample-request/astigmatism-market
Astigmatism Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Astigmatism market or expected to get launched during the study period. The analysis covers Astigmatism market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Astigmatism Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Astigmatism Therapeutics Analysis
The Astigmatism Pipeline is very bleak as only a few players are working in the therapeutics market. However, the Astigmatism market dynamics are anticipated to change immensely in the coming years owing to growth in the research and development activities so that market will comprise efficient treatment options.
Get More Detailed Insights Into the Emerging Therapies & Key Companies – https://www.delveinsight.com/sample-request/astigmatism-market
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Astigmatism Competitive Intelligence Analysis
4. Astigmatism Market Overview at a Glance
5. Astigmatism Disease Background and Overview
6. Astigmatism Patient Journey
7. Astigmatism Epidemiology and Patient Population
8. Astigmatism Treatment Algorithm, Current Treatment, and Medical Practices
9. Astigmatism Unmet Needs
10. Key Endpoints of Astigmatism Treatment
11. Astigmatism Marketed Products
12. Astigmatism Emerging Therapies
13. Astigmatism Seven Major Market Analysis
14. Attribute Analysis
15. Astigmatism Market Outlook (7 major markets)
16. Astigmatism Access and Reimbursement Overview
17. KOL Views on the Astigmatism Market.
18. Astigmatism Market Drivers
19. Astigmatism Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF Report – https://www.delveinsight.com/sample-request/astigmatism-market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Other Trending Healthcare Reports by DelveInsight
Carcinoid Tumor Syndrome Market
“Carcinoid Tumor Syndrome Market” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Carcinoid Tumor Syndrome Market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/